Literature DB >> 16330559

Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study.

Hiroshi Yamauchi1, Takashi Kudoh, Yoshihiko Kishibe, Jinei Iwasaki, Shinya Kagawa.   

Abstract

UNLABELLED: The pathogenesis of selective neuronal damage in internal carotid artery (ICA) occlusive disease is unclear. Imaging of the central-type benzodiazepine receptor (BZR), which is expressed by most cortical neurons, provides information on the neuronal alterations induced by ischemia in vivo. Hemodynamic ischemia due to ICA occlusive disease may cause not only borderzone infarction but also selective neuronal damage beyond the regions of infarcts, which may be detected by a decrease in BZR in the normal-appearing cerebral cortex. The purpose of this study was to determine whether selective neuronal damage is associated with borderzone infarction in ICA occlusive disease.
METHODS: We measured BZR using PET and 11C-flumazenil in 62 nondisabled patients with ICA steno-occlusive lesions in the chronic stage. Flumazenil binding potential (BP) was calculated using the dynamic data and the reference tissue model. The infarcts on MRI-which were categorized as territorial, borderzone (external or internal), striatocapsular, lacunar, and other white matter infarcts-were correlated with the mean cerebral/cerebellar cortical BP ratio in the hemisphere with ICA occlusive disease.
RESULTS: Patients with borderzone infarction (n=18) had a significantly decreased flumazenil BP ratio in the hemisphere with ICA occlusive disease compared with patients without borderzone infarction (n=44) and healthy control subjects (n=10). Multivariate analysis showed that external borderzone infarction was an independent predictor of the decreased flumazenil BP ratio.
CONCLUSION: In ICA occlusive disease, selective neuronal damage demonstrated as decreased BZR is associated with borderzone infarction, suggesting that hemodynamic ischemia leading to borderzone infarction may cause selective neuronal damage beyond the regions of infarcts in the chronic stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330559

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  GABAA receptor deficits predict recovery in patients with disorders of consciousness: A preliminary multimodal [(11) C]Flumazenil PET and fMRI study.

Authors:  Pengmin Qin; Xuehai Wu; Niall W Duncan; Weiqi Bao; Weijun Tang; Zhengwei Zhang; Jin Hu; Yi Jin; Xing Wu; Liang Gao; Lu Lu; Yihui Guan; Timothy Lane; Zirui Huang; Yelena G Bodien; Joseph T Giacino; Ying Mao; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2015-07-03       Impact factor: 5.038

2.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

3.  Silent cortical neuronal damage in atherosclerotic disease of the major cerebral arteries.

Authors:  Hiroshi Yamauchi; Ryuichi Nishii; Tatsuya Higashi; Shinya Kagawa; Hidenao Fukuyama
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

4.  Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery.

Authors:  Hiroshi Yamauchi; Ryuichi Nishii; Tatsuya Higashi; Shinya Kagawa; Hidenao Fukuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-27       Impact factor: 10.154

5.  The relationship of cortical folding and brain arteriovenous malformations.

Authors:  Manish N Shah; Sarah E Smith; Donna L Dierker; Joseph P Herbert; Timothy S Coalson; Brent S Bruck; Gregory J Zipfel; David C Van Essen; Ralph G Dacey
Journal:  Neurovasc Imaging       Date:  2016-11-22

6.  Cerebrovascular risk factors for patients with cerebral watershed infarction: A case-control study based on computed tomography angiography in a population from Southwest China.

Authors:  Mei-Xue Dong; Ling Hu; Yuan-Jun Huang; Xiao-Min Xu; Yang Liu; You-Dong Wei
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

7.  Selective neuronal damage and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Kuninori Kusano; Chio Okuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-05-24       Impact factor: 10.154

Review 8.  Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease-A clinico-radiological and neuroscientific perspective.

Authors:  Freimut D Juengling; Frank Wuest; Sanjay Kalra; Federica Agosta; Ralf Schirrmacher; Alexander Thiel; Wolfgang Thaiss; Hans-Peter Müller; Jan Kassubek
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

9.  Recovery of Repressed Memories in Fibromyalgia Patients Treated With Hyperbaric Oxygen - Case Series Presentation and Suggested Bio-Psycho-Social Mechanism.

Authors:  Shai Efrati; Amir Hadanny; Shir Daphna-Tekoah; Yair Bechor; Kobi Tiberg; Nimrod Pik; Gil Suzin; Rachel Lev-Wiesel
Journal:  Front Psychol       Date:  2018-05-29

Review 10.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.